Covetrus, Inc. Common Stock
CVET
CVET was delisted on the 12th of October, 2022.
340 hedge funds and large institutions have $2.91B invested in Covetrus, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 340 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
26% more call options, than puts
Call options by funds: $4.44M | Put options by funds: $3.52M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CDR
Clayton Dubilier & Rice
New York
|
+$400M |
| 2 |
Morgan Stanley
New York
|
+$373M |
| 3 |
BlackRock
New York
|
+$271M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$239M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$210M |
Top Sellers
CVET Hedge Fund Activity: Q1 2019 in Review
340 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Covetrus, Inc. Common Stock (CVET) for Q1 2019, worth a combined $2.91B.
Buyers outnumbered sellers: 340 funds opened new CVET positions and 0 closed out — a net gain of 340 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Clayton Dubilier & Rice, opening a new position worth an estimated $400M.
- 340 institutional investors held Covetrus, Inc. Common Stock (CVET) as of Q1 2019, up from 0 in Q4 2018.
- Funds reported $2.91B of Covetrus, Inc. Common Stock stock for Q1 2019.
- 340 funds opened new Covetrus, Inc. Common Stock positions in Q1 2019 and 0 closed out, a net change of +340 holders.
- The largest Covetrus, Inc. Common Stock buyer in Q1 2019 was Clayton Dubilier & Rice, an estimated $400M added.
Based on aggregated 13F filings for Q1 2019.